Former Teva CEO's new gig at Ovid Therapeutics

Leading a startup focused on rare neurological disorders may not be an obvious transition for someone who helmed the world's largest generic drug maker, but that's exactly what Jeremy Levin set out to do after his abrupt departure from Israel's Teva in 2013.